2021年6月11日全球新冠肺炎疫情及疫苗接种简报:日新增41.6万,全球争相研发第二代新冠疫苗

2021-06-11 MedSci整理 MedSci整理

截至北京时间2021年6月11日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17558万例,新增416,835例,达到175,586,75

截至北京时间2021年6月11日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过17558万例,新增416,835例,达到175,586,755例。累计死亡病例378.7万例,达到3,787,486例。新增死亡为10,675例。康复为159,439,774例,重症和危重症病人达到84,884例;全球新冠确诊病例超过100万例的国家达28个,94个国家病例超10万例。昨日报道:2021年6月10日全球新冠肺炎疫情及疫苗接种简报:日新增40.2万,我国又一新冠灭活疫苗上市使用

中国台湾自产重组蛋白疫苗二期试验“果然”解盲成功

高端研发的COVID-19疫苗今天进行二期临床试验解盲记者会,公告二期临床数据,结果显示安全性与耐受性良好,所有受试者未出现疫苗相关严重不良反应。

高端今日公布疫苗解盲结果,是指二期临床试验数据“安全性”与“免疫生成性”两大项,“免疫生成性”就是指抗体在人体内的浓度。二期临床试验数据达到“食药署”(TFDA)标准,就可顺利申请紧急授权许可(EUA)。

据言,其抗体滴度可能比mRNA疫苗还要高。

上海新冠疫苗接种突破3000万剂次!1806.36万人已接种第一剂次

来自上海市卫健委最新统计数据显示,截至6月9日20时,全市累计接种3024.92万剂,1806.36万人已接种第一剂次,1256.39万人完成全程接种。其中,在沪外籍人士累计接种59892剂,在沪港澳同胞累计接种11475剂,在沪台胞累计接种27846剂。

在加快推进疫苗接种覆盖率的过程中,各行各业都在积极响应号召,贡献自己的“一臂之力”。

日本报告196人接种辉瑞新冠疫苗后死亡

据日本厚生劳动省10日发表的最新统计,截至本月4日,日本有196人在接种辉瑞新冠疫苗后死亡。不过,日本政府尚未确认死亡案例和接种疫苗有直接因果关系。

此外,日本警察厅统计发现,去年3月以来,已有至少500人在感染新冠病毒后的居家隔离期间因病情恶化而死亡,其中今年5月有97人。

统计还显示,截至9日,日本已接种新冠疫苗超过2000万剂,约516万人完成两剂接种。日本首相菅义伟9日表示,希望在10月到11月为全部有意接种者完成接种。

全球竞相研发第二代新冠疫苗

美国食品药品监督管理局(FDA)已经要求制药公司调整技术,研发针对新冠病毒新变种和未来变种的疫苗。为此,莫德纳和辉瑞公司已经在开发所谓第二代疫苗。

据阿根廷布宜诺斯艾利斯经济新闻网6月6日报道,莫德纳宣布从三条战线研发第二代疫苗。首先,它已经研发出一种专门针对南非变种的新疫苗mRNA-1273.351,并且首批疫苗已经送往相关机构接受评估,他们希望将这个新疫苗作为前两剂一代疫苗的补充,或者作为未接种人士的新选择。第二条线是研发多用途疫苗。第三条线是莫德纳正在研发的一款疫苗,它使用的信使RNA比当前疫苗少100微克,目前有些志愿者已经接种了这些信使RNA含量较少的疫苗。

辉瑞公司也像莫德纳一样在测试第三剂疫苗是否可以作为能够中和变异体的加强剂,并与德国拜恩泰科公司共同研发第二代疫苗,目前,这两家公司正在招募新志愿者参加一期和二期研究。

上述实验室的研发行动将遵循FDA的建议,即目前的二代疫苗不必经过冗长的第一、第二和第三阶段试验,只需在数百名此前未曾接种新冠疫苗的志愿者身上证明二代疫苗能够刺激人体免疫系统,或者在已接种疫苗的志愿者身上证明加强剂的效果就行。

除了这两家公司,其他制药公司或者大学研发的18款更廉价、易于生产和多用途的二代新冠疫苗,也正处于临床研究的最后阶段。

国家卫健委:昨日新增确诊病例21例 本土病例6例均在广东

国家卫健委数据显示,6月9日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例21例,其中境外输入病例15例(上海7例,广东3例,陕西2例,浙江1例,四川1例,云南1例),本土病例6例(均在广东);无新增死亡病例;无新增疑似病例。

温州市境外输入确诊病例的密接者已检验出两例核酸阳性

温州发布消息,截至6月10日14时,全市已排查密切接触者242人,次密接829人,全部落实管控。完成核酸检测采样72791人,已出检测结果14554份,其中14552份为阴性,2份阳性。

G7计划明年追加10亿剂新冠疫苗

七国集团草案显示,G7计划明年追加10亿剂新冠疫苗,在2022年结束新冠疫情;支持关于新冠检测和疫苗接种的共同旅行标准;敦促俄罗斯方面打击勒索软件和网络攻击;确保长期内公共融资的可持续性。

世贸组织将针对豁免新冠疫苗知识产权展开谈判

当地时间9日,世贸组织各成员同意于6月17日启动谈判,讨论如何增加新冠疫苗供应等问题,主要争论焦点在于是否豁免新冠疫苗知识产权。据日内瓦贸易官员透露,此次谈判启动后,预计将在7月21日至22日举行的世贸组织总理事会前得出一份报告,介绍增加疫苗供应计划的谈判进展。

据媒体援引权威渠道消息,近日举行的《与贸易有关的知识产权协定》理事会正式会议上,WTO成员同意就新冠疫苗专利豁免提案举行基于文本的程序,最早六月中旬开启。

中国疫苗接种情况

据国家卫生健康委员会官网消息,截至2021年6月8日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗80896.2万剂次。

上一日累计报告接种新冠病毒疫苗80896.2万剂次,新增1589.4万剂次

全球疫苗接种情况

Country
Cumulative COVID-19 vaccinations doses
World 2.26 billion
Asia 1.28 billion
Upper middle income 1.11 billion
China 824.86 million
High income 810.95 million
Europe 402.34 million
North America 383.70 million
Lower middle income 323.02 million
United States 304.75 million
European Union 282.74 million
India 236.86 million
South America 137.87 million
Brazil 74.81 million
United Kingdom Jun 8, 2021 69.25 million
England Jun 8, 2021 58.21 million
Germany 57.89 million
France Jun 7, 2021 40.84 million
Italy 39.89 million
Africa 39.72 million
Mexico Jun 8, 2021 35.17 million
Turkey 31.99 million
Russia 31.61 million
Spain Jun 8, 2021 31.00 million
Indonesia 30.16 million
Canada 27.26 million
Poland 23.24 million
Japan 20.38 million
Chile Jun 8, 2021 19.83 million
Morocco 16.04 million
Saudi Arabia 15.36 million
Argentina 15.01 million
United Arab Emirates 13.51 million
South Korea 12.14 million
Colombia Jun 7, 2021 11.73 million
Netherlands 10.91 million
Israel 10.61 million
Bangladesh Jun 8, 2021 10.05 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-12 lqvr
  3. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 亭儿999

    继续学习中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 姜暮烟齐

    学习、了解

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 145c67fem57暂无昵称

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 weigq

    加油!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 ms4000001674019570

    S中国做的真的没问题

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1258020, encodeId=3933125802055, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1300472, encodeId=331613004e24d, content=<a href='/topic/show?id=ed5ee332423' target=_blank style='color:#2F92EE;'>#研发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73324, encryptionId=ed5ee332423, topicName=研发)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aea0290, createdName=lqvr, createdTime=Sat Jun 12 22:34:31 CST 2021, time=2021-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972800, encodeId=efde9e280064, content=继续学习中, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/f7616d040e6842afb334fb7dc7fe70d5/b02af0ca19f148e6988b157b7f6cd6e8.jpg, createdBy=b4eb5518910, createdName=亭儿999, createdTime=Fri Jun 11 11:25:35 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972796, encodeId=fcc89e279673, content=学习、了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210608/51c7a6ec823b48b0a2e6ce6b33750a4d/eed743a7daa04521992a517ea31bd518.jpg, createdBy=fa565516283, createdName=姜暮烟齐, createdTime=Fri Jun 11 11:18:32 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029583, encodeId=88a21029583ed, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Fri Jun 11 10:34:31 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972782, encodeId=b2ae9e278274, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210611/cc33312c1369486884dd2d78fa6be682/0c34f5e4c3b84bf4a04dcb52b2aec718.jpg, createdBy=8b7f5087263, createdName=145c67fem57暂无昵称, createdTime=Fri Jun 11 10:32:18 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972761, encodeId=83ff9e276146, content=加油!, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210703/9c448fe1b3b54fd7bc9477662f4861bb/4bdadad22bfd46f2921aabb4c40265d3.jpg, createdBy=a8d81938466, createdName=weigq, createdTime=Fri Jun 11 08:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972752, encodeId=6cfd9e2752cc, content=S中国做的真的没问题, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210812/45d0ab70399349acbd75bd5739f2b9d2/1d302e27a7fd4b1cb0f7c726e8470e35.jpg, createdBy=f54c5518469, createdName=ms4000001674019570, createdTime=Fri Jun 11 08:41:46 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972742, encodeId=fdb89e274293, content=认真学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b3545492917, createdName=smart Ren, createdTime=Fri Jun 11 07:57:07 CST 2021, time=2021-06-11, status=1, ipAttribution=)]
    2021-06-11 smart Ren

    认真学习

    0

相关资讯

台湾高端疫苗公布二期试验数据,第二剂后28天的血清阳转率达99.8%?

疫苗组在施打第二剂后28天的血清阳转率(seroconversion rate)达99.8%

2021年6月8日全球新冠肺炎疫情及疫苗接种简报:日新增29.4万,广东省疫苗接种提速,国内计划上半年完成40%人口完全免疫

截至北京时间2021年6月8日6时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17434万例,新增294,428例,达到174,346,176

2021年6月9日全球新冠肺炎疫情及疫苗接种简报:日新增34.2万,全球多国超过50%人口至少接种过一剂新冠疫苗

截至北京时间2021年6月9日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17471万例,新增342,141例,达到174,714,942

2021年6月7日全球新冠肺炎疫情及疫苗接种简报:日新增31.3万,广东省疫苗接种提速,国内计划上半年完成40%人口完全免疫

截至北京时间2021年6月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17402万例,新增312,823例,达到174,026,732

海南新冠疫苗累计接种人数突破700万,全人群接种率达70%,18岁以达90.7%

海南省坚决贯彻落实国务院联防联控机制工作部署,把疫苗接种作为疫情防控最重要的政治任务,积极稳妥有序推进,不断巩固海南省疫情防控成果。截至2021年6月3日,全省已累计接种700.4万人、1263.24

2021年6月10日全球新冠肺炎疫情及疫苗接种简报:日新增40.2万,我国又一新冠灭活疫苗上市使用

截至北京时间2021年6月10日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17514万例,新增402,440例,达到175,145,69